Micellar extraction possesses a new advantage for the analysis of Alzheimer’s disease brain proteome

Sravani Musunuri(Uppsala University), Ganna Shevchenko(Uppsala University), Bernhard Clemens Richard(University of Göttingen), Jonas Bergquist(Uppsala University), Kim Kultima(Uppsala University), Lars Lannfelt(BioArctic Neuroscience (Sweden)), Martin Ingelsson(Uppsala University)
Analytical and Bioanalytical Chemistry
November 21, 2014
10.1007/s00216-014-8320-8
Cited by 7

Related Papers

Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
|Science|2005|2k
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
|PLoS ONE|2010|1k
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
|Neurology|2004|655
High levels of AAV vector integration into CRISPR-induced DNA breaks
|Nature Communications|2019|430